Nike ( NKE ) keeps bleeding. In the past three months, it lost almost 12%, even though its Q1 FY26 results topped estimates (which, to be fair, were low). Perhaps investors still remember how Nike performed well during the pandemic, with the stockI’m a long-term investor focused on U.S. and European equities, with a dual emphasis on undervalued growth stocks and high-quality dividend growers. Through years of experience, I’ve learned that sustained profitability—evident in strong margins, stable and expandi ...